Marksans Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma has informed the stock exchanges that the trading window for its designated persons and their immediate relatives will remain closed from Wednesday, October 1, 2025 until 48 hours after the declaration of its unaudited financial results for the quarter and half year ending September 30, 2025. This is a standard compliance measure taken under SEBI's Prohibition of Insider Trading Regulations, 2015, meaning company insiders cannot buy or sell shares during this period. The exact date of the results announcement will be communicated separately.
This is a routine regulatory filing and does not directly affect the stock price. It does, however, signal that the company's Q2 and H1 FY26 results are likely due in the coming weeks, which is when investors should look out for actual business performance updates.